Ingrid Gause-Nilsson

Ingrid Gause-Nilsson

UNVERIFIED PROFILE

Are you Ingrid Gause-Nilsson?   Register this Author

Register author
Ingrid Gause-Nilsson

Ingrid Gause-Nilsson

Publications by authors named "Ingrid Gause-Nilsson"

Are you Ingrid Gause-Nilsson?   Register this Author

19Publications

483Reads

-Profile Views

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2019 01 10;380(4):347-357. Epub 2018 Nov 10.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital (S.D.W., M.P.B., T.A.Z., J.F.K., S.A.M., D.L.B., C.T.R., M.S.S.), and the Cardiology Division, Massachusetts General Hospital (M.G.S.) - both in Boston; the Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem (I.R., O.M., A.C.); the Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (E.T.K.); Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom (J.P.H.W.); and AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., P.A.J., A.-M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812389DOI Listing
January 2019

DECLARE-TIMI 58: Participants' baseline characteristics.

Diabetes Obes Metab 2018 05 14;20(5):1102-1110. Epub 2018 Feb 14.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13217DOI Listing
May 2018

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.

J Diabetes Complications 2017 Jul 10;31(7):1215-1221. Epub 2017 Feb 10.

AstraZeneca, Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2017.02.001DOI Listing
July 2017

Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.

Cardiovasc Diabetol 2016 Feb 19;15:37. Epub 2016 Feb 19.

AstraZeneca Gothenburg, Pepparedsleden 1, SE-431 83, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12933-016-0356-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761166PMC
February 2016

Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension.

J Am Geriatr Soc 2014 Jul 2;62(7):1252-62. Epub 2014 Jun 2.

Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://pharmacy.hsc.wvu.edu/media/1897/dapigliflozin-aded-to
Web Search
http://doi.wiley.com/10.1111/jgs.12881
Publisher Site
http://dx.doi.org/10.1111/jgs.12881DOI Listing
July 2014

Efficacy and safety of saxagliptin in drug-naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial.

Diabetes Metab Res Rev 2012 Mar;28(3):268-75

Department of Endocrinology, General Hospital of Chinese People's Liberation Army, Beijing, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/dmrr.1306
Publisher Site
http://dx.doi.org/10.1002/dmrr.1306DOI Listing
March 2012

Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trial.

Diabetes Res Clin Pract 2011 Nov 26;94(2):217-24. Epub 2011 Aug 26.

Department of Endocrinology, China-Japan Friendship Hospital, Yinhua No 2 East Road, Hepingli, Chao Yang District, Beijing 100029, China.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016882271100411
Publisher Site
http://dx.doi.org/10.1016/j.diabres.2011.07.035DOI Listing
November 2011

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.

Diabetes Metab Res Rev 2010 Oct;26(7):540-9

University of Liège, Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Liège, Liège, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/dmrr.1114
Publisher Site
http://dx.doi.org/10.1002/dmrr.1114DOI Listing
October 2010

Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes.

Diab Vasc Dis Res 2007 Sep;4(3):194-203

Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2007.040DOI Listing
September 2007

The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes.

Diab Vasc Dis Res 2007 Sep;4(3):204-13

Department of Internal Medicine II, University of Munich-Grosshadern, Marchinioninstr. 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2007.041DOI Listing
September 2007

Risk group for hip fracture in elderly women identified by primary care questionnaire--clinical implications.

Ups J Med Sci 2006 ;111(2):179-87

Department of Primary Health Care, Gothenburg University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/2000-1967-034DOI Listing
December 2006

Postural balance in elderly people: changes over a five-year follow-up and its predictive value for survival.

Aging Clin Exp Res 2002 Jun;14(3 Suppl):37-46

Finnish Centre for Interdisciplinary Gerontology, Department of Health Sciences, University of Jyväskylä, and Brain Research and Rehabilitation Center Neuron.

View Article

Download full-text PDF

Source
June 2002